Moxie Secures $25M for Aesthetic Medicine Dominance
March 11, 2026, 3:41 pm
Moxie secured $25 million in Series C funding, increasing total capital to $51 million. This investment propels Moxie's mission: professionalizing independent aesthetic medicine practices. Its clinical-grade operating system delivers crucial infrastructure. The company also unveiled Scale Suite. This new offering brings multi-provider management, margin intelligence, and AI-driven compliance to medspas. Funding will accelerate platform development and expand market reach. Moxie aims to empower clinicians, fostering disciplined growth in a booming sector.
Moxie announced a significant financial milestone. It closed a $25 million Series C funding round. Viewpoint Ventures led the investment. SignalFire, Lachy Groom, and Haystack also participated. This capital injection raises Moxie’s total funding to $51 million. The company aims to revolutionize the aesthetic medicine industry. Its core mission: deliver robust operational infrastructure to independent practices.
The aesthetic medicine market is booming. The U.S. sector will reach an estimated $18 billion by 2025. Medspas have surged in popularity. They grew from under 5,000 in 2010 to over 15,000 today. This rapid expansion presents challenges. Many clinicians lack formal business training. They manage finances, operations, compliance, and hiring alone. Large chains or private equity-backed groups enjoy extensive support. Independent practices often struggle without similar infrastructure. This creates a critical gap in the market. Efficient practice management is often missing.
Moxie bridges this gap. It provides a clinical-grade operating system. This integrated platform combines software, coaching, and compliance infrastructure. It is specifically tailored for the aesthetics industry. Moxie’s approach emphasizes "clinically-led growth." This means strong clinical standards meet operational discipline. Financial transparency and regulatory compliance are paramount. The platform integrates Electronic Medical Records (EMR) with financial reporting and inventory tracking. It provides essential tools for daily operations. This holistic system elevates independent aesthetic practices.
Moxie's impact is quantifiable. Practices utilizing its platform grow 60% faster than the industry average. They achieve 10% higher margins. These businesses save over $5,000 monthly on products and supplies. Customer retention stands at an impressive 97%. Over 20% of new practices join through referrals. Moxie currently supports more than 700 aesthetic practices across the United States. These metrics underscore its effectiveness and market acceptance. Moxie provides a proven pathway to success.
The company simultaneously launched Scale Suite. This new product offering marks a significant expansion. Scale Suite delivers multi-provider operational infrastructure. It includes margin intelligence tools. It also features AI-driven compliance capabilities. This suite empowers independent practices. It enables them to operate and scale more effectively. It brings sophistication previously reserved for larger entities. Scale Suite addresses the complex demands of modern medspas.
Scale Suite offers comprehensive tools. Practice 360 assessments analyze over 300 operational and financial data points. These insights span workflows and performance metrics. Multi-provider practice management tools integrate with Moxie’s EMR platform. They streamline scheduling, payroll, and operational controls. These features are precisely tailored for aesthetic medicine workflows. They ensure seamless business infrastructure.
Moxie Capital provides financing solutions. It pairs this with a proprietary decision framework. This guides practice investments wisely. Recruiting support assists practices in expanding teams. It covers both clinical and operational roles. Maia, an AI-powered practice assistant, enhances efficiency. It supports compliance monitoring, inventory management, and patient inquiries. This AI innovation automates critical tasks.
Margin intelligence tools offer crucial financial clarity. They provide detailed financial reporting. Service-level profitability analysis is available. Pricing guidance and compensation modeling improve business decisions. Compliance and regulatory safeguards are built-in. These include automated alerts and audit-ready documentation. The platform ensures practices meet stringent industry standards. It protects both practitioners and patients.
Moxie also offers Clinical Business Mastery. This is an education program. It includes a playbook library. Physicians, injectors, and operators in aesthetic medicine developed it. This advisory board ensures industry relevance. Moxie cultivates the Scale Society community. This network connects aesthetic practice owners. It fosters shared learning and growth. This collective intelligence strengthens the entire sector.
The new Series C funding fuels ambitious plans. It will accelerate Scale Suite platform development. Clinical education and advisory programs will expand. The Scale Society community will grow further. Moxie will invest in its engineering and operational teams. This supports a rapidly expanding customer base. Moxie is poised to continue its leadership. It drives innovation in aesthetic practice management. It elevates professional standards across the aesthetic medicine sector. Its vision ensures independent practices thrive.
Moxie announced a significant financial milestone. It closed a $25 million Series C funding round. Viewpoint Ventures led the investment. SignalFire, Lachy Groom, and Haystack also participated. This capital injection raises Moxie’s total funding to $51 million. The company aims to revolutionize the aesthetic medicine industry. Its core mission: deliver robust operational infrastructure to independent practices.
The aesthetic medicine market is booming. The U.S. sector will reach an estimated $18 billion by 2025. Medspas have surged in popularity. They grew from under 5,000 in 2010 to over 15,000 today. This rapid expansion presents challenges. Many clinicians lack formal business training. They manage finances, operations, compliance, and hiring alone. Large chains or private equity-backed groups enjoy extensive support. Independent practices often struggle without similar infrastructure. This creates a critical gap in the market. Efficient practice management is often missing.
Moxie bridges this gap. It provides a clinical-grade operating system. This integrated platform combines software, coaching, and compliance infrastructure. It is specifically tailored for the aesthetics industry. Moxie’s approach emphasizes "clinically-led growth." This means strong clinical standards meet operational discipline. Financial transparency and regulatory compliance are paramount. The platform integrates Electronic Medical Records (EMR) with financial reporting and inventory tracking. It provides essential tools for daily operations. This holistic system elevates independent aesthetic practices.
Moxie's impact is quantifiable. Practices utilizing its platform grow 60% faster than the industry average. They achieve 10% higher margins. These businesses save over $5,000 monthly on products and supplies. Customer retention stands at an impressive 97%. Over 20% of new practices join through referrals. Moxie currently supports more than 700 aesthetic practices across the United States. These metrics underscore its effectiveness and market acceptance. Moxie provides a proven pathway to success.
The company simultaneously launched Scale Suite. This new product offering marks a significant expansion. Scale Suite delivers multi-provider operational infrastructure. It includes margin intelligence tools. It also features AI-driven compliance capabilities. This suite empowers independent practices. It enables them to operate and scale more effectively. It brings sophistication previously reserved for larger entities. Scale Suite addresses the complex demands of modern medspas.
Scale Suite offers comprehensive tools. Practice 360 assessments analyze over 300 operational and financial data points. These insights span workflows and performance metrics. Multi-provider practice management tools integrate with Moxie’s EMR platform. They streamline scheduling, payroll, and operational controls. These features are precisely tailored for aesthetic medicine workflows. They ensure seamless business infrastructure.
Moxie Capital provides financing solutions. It pairs this with a proprietary decision framework. This guides practice investments wisely. Recruiting support assists practices in expanding teams. It covers both clinical and operational roles. Maia, an AI-powered practice assistant, enhances efficiency. It supports compliance monitoring, inventory management, and patient inquiries. This AI innovation automates critical tasks.
Margin intelligence tools offer crucial financial clarity. They provide detailed financial reporting. Service-level profitability analysis is available. Pricing guidance and compensation modeling improve business decisions. Compliance and regulatory safeguards are built-in. These include automated alerts and audit-ready documentation. The platform ensures practices meet stringent industry standards. It protects both practitioners and patients.
Moxie also offers Clinical Business Mastery. This is an education program. It includes a playbook library. Physicians, injectors, and operators in aesthetic medicine developed it. This advisory board ensures industry relevance. Moxie cultivates the Scale Society community. This network connects aesthetic practice owners. It fosters shared learning and growth. This collective intelligence strengthens the entire sector.
The new Series C funding fuels ambitious plans. It will accelerate Scale Suite platform development. Clinical education and advisory programs will expand. The Scale Society community will grow further. Moxie will invest in its engineering and operational teams. This supports a rapidly expanding customer base. Moxie is poised to continue its leadership. It drives innovation in aesthetic practice management. It elevates professional standards across the aesthetic medicine sector. Its vision ensures independent practices thrive.